2nd Annual Bispecifics in Discovery & Development Congress
Oxford Global’s 2nd Annual Bispecifics in Discovery & Development Congress will be attended by over 450 visionary leaders to network about the latest developments & participate in presentations from the areas of engineering, bioanalysis, biotherapeutics and bispecifics.
New for 2020 is the introduction of the kick-off sessions, providing an interactive experience for delegates through roundtable & panel discussions.
Key Speakers Include:
- Tristan Vaughan, Vice President, AstraZeneca
- John McCafferty, Chief Executive Officer, IONTAS Pharmaceuticals
- Surinder Kaur, Director, Genentech
- Kristin Brown, Director, GlaxoSmithKline
VIEW AGENDA: https://bit.ly/30vvvXx
Part of the Biologics Series, it is co-located the 13th Annual Proteins & Antibodies Congress and the 7th Annual Peptides & Oligonucleotides Congress.
2020 Live Webinar:
“Bispecific Antibodies Targeting The Innate Immune Checkpoint CD47
Presented by Nicolas Fischer, Chief Executive Officer, Light Chain Bioscience
Tuesday 21st January 2020 | 2PM UK GMT
REGISTER FOR FREE: https://bit.ly/2sAyHUM
Go Social: Join our Proteins Network on LinkedIn, follow us on Twitter at @biologicsconf and join the conversation using the hashtag #Biologics20
For more information about the event, please contact Bradley Copeman at email@example.com or visit the website: https://bit.ly/2RlkT9v
Date: 27 - 29 April 2020
Location: London, UK
There are no comments yet. You can be the first.
Leave a Reply cancel reply
Your email address will not be published. Required fields are marked *